In summary, through clinical samples combined within vitro tumor cell line and mouse xenograft model experiments, we demonstrated for the first time that CDKN2AIP induces testicular seminoma cell senescence and suppresses CARM1 expression and eIF4β phosphorylation. Here, CDKN2AIP is linked to neoplasm.